Davita Healthcare Partners, Inc. (NYSE:DVA)
CAPS Rating:
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
Recs
Warren Buffett has been buying DVA as though it were a cold Coke on a hot day. Fourth quarter 2012 purchases were at least 3.4 million shares, giving him over 14% of shares outstanding and a 33% increase in his position.